(no title)

OUR MISSION

FloBio is pioneering a novel point-of-care diagnostic platform that analyzes flowing blood to assess blood clotting function under physiologic conditions.

Our proprietary microfluidic technology is designed to take a more holistic approach, providing rapid and real-time measurements that are actionable, enabling clinicians to personalize management within the critical decision making window. FloBio, a spin-out of the University of Pennsylvania, was founded in 2017 by Scott L. Diamond, PhD, the Arthur E. Humphrey Professor at Penn Engineering and is based in Philadelphia, PA. The technology being developed is validated by over 10 years of research and more than 30 publications demonstrating the scientific foundation and proof of concept across a broad range of clinical and pharmacological situations where understanding bleeding and thrombotic risk is essential.